U.S. Advanced Wound Care Market, By Product Type (Dressing, Therapy Device, Biologics, Others), Wound Type (Primary Wound Care, Secondary Wound Care), Wound Class (Class I, Class II, Class III, Class IV), End-User (Hospitals, Wound Care Centres, Ambulatory Centres, Home Healthcare, Clinics, Others), Distribution Channel (Direct Tenders, Retail) – Industry Trends and Forecast to 2030.
U.S. Advanced Wound Care Market Analysis and Size
Advanced wound care is specialized products and treatments aimed at promoting wound healing in complex or chronic wounds. It includes advanced wound dressings, wound care devices, bioactive therapies, and other advanced wound care products.
Data Bridge Market Research analyzes that the U.S. advanced wound care market, which was USD 3,343.11 million in 2022, would rocket up to USD 7,334.55 million by 2030 and is expected to undergo a CAGR of 5.90% during the forecast period. “Dressing” is expected to dominate the product type segment of the U.S. advanced wound care market owing to the rising prevalence of chronic wounds.
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
U.S. Advanced Wound Care Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Year
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
By Product Type (Dressing, Therapy Device, Biologics, Others), Wound Type (Primary Wound Care, Secondary Wound Care), Wound Class (Class I, Class II, Class III, Class IV), End-User (Hospitals, Wound Care Centres, Ambulatory Centres, Home Healthcare, Clinics, Others), Distribution Channel (Direct Tenders, Retail)
|
|
Countries Covered
|
U.S.
|
|
Market Players Covered
|
EKCI Licensing, Inc. (U.S.), Smith and Nephew (U.K.), Medline Industries, Inc. (U.S.), 3M (U.S.), ConvaTec Group PLC (U.K.), Medtronic plc (Ireland), Mölnlycke Health Care AB (Sweden), Advancis Medical (U.K.), PAUL HARTMANN AG (Germany), Integra LifeSciences Corporation (U.S.), Organogenesis Holdings Inc. (U.S.), Coloplast Group (Denmark), B. Braun Melsungen AG (Germany), Baxter (U.S.), Johnson & Johnson Services, Inc. (U.S.), Anika Therapeutics, Inc. (U.S.), and ACell, Inc. (U.S.) among others
|
|
Market Opportunities
|
|
Market Definition
Advanced wound care is the specialized treatment and management of complex or chronic wounds that are difficult to heal using traditional wound care methods. It involves the use of advanced wound care products, techniques, and therapies to promote the healing process, reduce complications, and improve patient outcomes. Advanced wound care products encompass a range of specialized dressings, wound closure devices, bioactive therapies, and other innovative solutions designed to address specific wound characteristics. These products are developed with advanced materials and technologies to provide enhanced wound healing benefits.
U.S. Advanced Wound Care Market Dynamics
Drivers
- Rising prevalence of chronic wounds
The increasing incidence of chronic wounds, such as diabetic ulcers, pressure ulcers, and venous leg ulcers, is a key driver for the market. Factors such as aging population, diabetes prevalence, and lifestyle changes contribute to the growing number of chronic wounds, necessitating advanced wound care solutions.
- Technological advancements in wound care products
The continuous development of advanced wound care products, including innovative dressings, negative pressure wound therapy systems, and bioactive therapies drives market growth. These advancements aim to improve wound healing outcomes, reduce complications, and enhance patient comfort.
- Increasing awareness and education
Growing awareness among healthcare professionals and patients about the benefits of advanced wound care drives market expansion. Educational initiatives, conferences, and training programs help disseminate knowledge about advanced wound care techniques and products, leading to their increased adoption.
Opportunities
- Increasing aging population
The growing elderly population in the U.S., prone to chronic wounds, presents opportunities to expand the market. Older adults often require specialized wound care interventions, creating a demand for advanced wound care products and therapies.
- Focus on outpatient wound care
The shift towards outpatient wound care settings provides opportunities for the adoption of advanced wound care products. Outpatient wound care centers, home healthcare services, and ambulatory surgical centers can benefit from advanced wound care technologies, facilitating market growth.
Restraints/Challenges
- High cost of advanced wound care products
The cost of advanced wound care products can be a significant barrier, limiting their accessibility for some patients and healthcare facilities. The higher cost of these specialized products compared to traditional wound care options can pose challenges for adoption.
-
Stringent regulatory environment
The stringent regulatory requirements for advanced wound care products, including clinical trials and approvals, can delay product launches and increase development costs. Complying with these regulations poses challenges for manufacturers and may hinder market growth.
The U.S. advanced wound care market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the advanced wound care market Contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In July 2021, as per an article by NCBI, nearly 500 million people were estimated to be suffering from Diabetes Mellitus (D.M.), with a predicted startling increase in the coming years. In the U.S. alone, over USD 300 billion are spent annually on medical costs, resulting from lost workdays due to D.M.
U.S. Advanced Wound Care Market Scope
The U.S. advanced wound care market is segmented into five notable segments based on product type, wound type, wound class, end-user, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Type
- Dressing
- Therapy Device
- Biologics
- Others
Wound Type
- Primary Wound Care
- Secondary Wound Care
Wound Class
- Class I
- Class II
- Class III
- Class IV
End-User
- Hospitals
- Wound Care Centres
- Ambulatory Centres
- Home Healthcare
- Clinics
- Others
Distribution Channel
- Direct Tenders
- Retail
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The U.S. advanced wound care market also provides you with a detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the market, the impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for the historic period 2015-2020.
Competitive Landscape and U.S. Advanced Wound Care Market Share Analysis
The U.S. advanced wound care market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus related to the market.
Some of the major players operating in the U.S. advanced wound care market are:
- EKCI Licensing, Inc. (U.S.)
- Smith and Nephew (U.K.)
- Medline Industries, Inc. (U.S.)
- 3M (U.S.)
- ConvaTec Group PLC (U.K.)
- Medtronic plc (Ireland)
- Mölnlycke Health Care AB (Sweden)
- Advancis Medical (U.K.)
- PAUL HARTMANN AG (Germany)
- Integra LifeSciences Corporation (U.S.)
- Organogenesis Holdings Inc. (U.S.)
- Coloplast Group (Denmark)
- B. Braun Melsungen AG (Germany)
- Baxter (U.S.)
- Johnson & Johnson Services, Inc. (U.S.)
- Anika Therapeutics, Inc. (U.S.)
- ACell, Inc. (U.S.)
SKU-